Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the acceptance of three abstracts for a poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting to be held in San Diego, CA from November 1-5, 2023.

Details of the poster presentation are as follows:

Abstract Title: Assay Development and Quantitative Detection of ADI-001, a CD20-Targeted γδ1 CAR T Therapy, using AlloCell, a Universal Assay for Monitoring of “Off-the-Shelf” Allogeneic Cell Therapies

Poster/Abstract Number: 684

Presenting Authors: Jackie Wilde, MS & Monica Moreno, PhD

Date/Time: November 4, 2023, from 9:00 a.m. – 8:30 p.m. PDT

Abstract Title: ADI-925: An Allogeneic “Off-the-Shelf” Chimeric Adapter (CAd) γδ T Cell Therapy Targeting NKG2D Ligand-Expressing Cancers

Poster/Abstract Number: 265

Presenting Authors: Marissa Herrman, PhD

Date/Time: November 3, 2023, from 9:00 a.m. – 8:30 p.m. PDT

Abstract Title: Disruption of the Cytokine Signaling Checkpoint CIS Enhances Serial-Killing and Anti-Tumor Activity of CAR-Engineered γδ T Cells

Poster/Abstract Number: 246

Presenting Authors: Beibei Ding, PhD

Date/Time: November 4, 2023, from 9:00 a.m. – 8:30 p.m. PDT

These abstracts will be available as a supplement in the Journal for ImmunoTherapy of Cancer (JITC) on Tuesday, October 31, 2023 at 9:00 a.m. EDT on www.sitcancer.org.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs) and chimeric antigen adaptors (CAds), to enhance selective tumor targeting and facilitate innate and adaptive anti-tumor immune response for durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

Adicet Bio, Inc.

Investor and Media Contacts

Anne Bowdidge

[email protected]

Janhavi Mohite

Stern Investor Relations, Inc.

212-362-1200

[email protected]

KEYWORDS: California Massachusetts United States North America

INDUSTRY KEYWORDS: Science Biotechnology Research Pharmaceutical Oncology Health Genetics Clinical Trials

MEDIA:

Logo
Logo

Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Presentations to highlight new nonclinical data on product candidates, new technologies, innovations designed to shorten TIL manufacturing and clinical trials in progress

SOUTH SAN FRANCISCO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, announced today that six abstracts highlighting its broad pipeline of clinical and preclinical product candidates as well as a shortened TIL manufacturing process have been accepted for presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) taking place in San Diego, Nov. 1-5, 2023.

“Our presentations at SITC highlight the progress we are making on several fronts to advance new product candidates and technologies designed to generate potent and durable cell therapies for patients with solid tumors,” stated Dr. Gary Lee, chief scientific officer at Lyell. “At SITC, we look forward to sharing new preclinical findings on product candidates and emerging technologies, data on our Epi-R P2 manufacturing process which is designed to shorten TIL product delivery time to patients, and highlighting the design of our two ongoing Phase 1 clinical trials in progress.”

Four presentations highlight new nonclinical data from pipeline product candidates and research programs, including a new technology being advanced through a collaboration with Outpace to enable context-dependent, localized IL-12 activity to enhance solid tumor T cell therapies; and Lyell’s novel Epi-R P2 manufacturing process to shorten manufacturing time for tumor infiltrating lymphocyte (TIL) therapy.

Two additional presentations highlight the design of Lyell’s ongoing Phase 1 clinical trials in progress: LYL797, a ROR1-targeted CAR T-cell therapy being evaluated in a Phase 1 trial in patients with relapsed refractory triple-negative breast cancer and non-small cell lung cancer, and LYL845, a tumor infiltrating lymphocyte (TIL) therapy being evaluated in a Phase 1 trial in advanced solid tumors.

Details on the six poster presentations are below:

Epi-R™ P2 protocol produces a scalable polyclonal TIL product with a greater expansion success rate across hot and cold tumors in shorter culture time

  • Presentation Date & Time: Friday, Nov. 3, 12–1:30 p.m. and 5:10–6:40 p.m.
  • Abstract Number: 379

Preclinical development of LYL119, a ROR1-targeted CAR T-cell product incorporating four novel T-cell reprogramming technologies to overcome barriers to effective cell therapy for solid tumors 

  • Presentation Date & Time: Saturday, Nov. 4, 2023, 11:55–1:25 p.m. and 7–8:30 p.m.
  • Abstract No.: 278

Protein design and inducible expression allow context-dependent, localized IL-12 activity to enhance solid tumor T cell therapies 

  • Presentation Date & Time: Friday, Nov. 3, 12–1:30 p.m. and 5:10–6:40 p.m.
  • Abstract No.: 1047

Rejuvenation of tumor

infiltrating lymphocyte
s
(TIL) through Partial Reprogramming

  • Presentation Date & Time: Friday, Nov. 3, 2023, 12–1:30 p.m. and 5:10–6:40 p.m. 
  • Abstract No.: 393

Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)

  • Presentation Date & Time: Saturday, Nov. 4, 2023, 11:55–1:25 p.m. and 7–8:30 p.m.
  • Abstract Number: 754

Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors

  • Presentation Date & Time: Friday, Nov. 3, 2023, 12–1:30 p.m. and 5:10–6:40 p.m.
  • Abstract No.: 747

About Lyell Immunopharma, Inc.

Lyell is a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors. Lyell is currently enrolling a Phase 1 clinical trial evaluating a ROR1-targeted CAR T-cell therapy in patients with relapsed refractory triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) and a second Phase 1 clinical trial evaluating reprogrammed tumor infiltrating lymphocytes (TIL) in patients with advanced melanoma, NSCLC and colorectal cancer. The technologies powering its product candidates are designed to address barriers that limit consistent and long-lasting responses to cell therapy for solid tumors: T-cell exhaustion and lack of durable stemness, which includes the ability to persist and self-renew to drive durable tumor cytotoxicity. Lyell is applying its proprietary ex vivo genetic and epigenetic reprogramming technologies to address these barriers in order to develop new medicines with improved durable clinical outcomes. Lyell is based in South San Francisco, California with facilities in Seattle and Bothell, Washington. To learn more, please visit www.lyell.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding: Lyell’s anticipated progress, business plans, business strategy and planned clinical trials; the growing pipeline and potential clinical benefits and therapeutic potential of Lyell’s product candidates; the potential for the Epi-R P2 manufacturing process to produce a scalable polyclonal TIL product with a greater expansion success rate across hot and cold tumors in shorter culture time; Lyell’s collaboration with Outpace Bio and the potential to enable context-dependent, localized IL-12 activity to enhance solid tumor T cell therapies; the potential of Lyell’s reprogramming technologies to overcome primary barriers to successful adoptive cell therapy in solid tumors to improve clinical responses in patients; the potential for Lyell’s rejuvenation of TIL through partial reprogramming; and other statements that are not historical fact. These statements are based on Lyell’s current plans, objectives, estimates, expectations and intentions, are not guarantees of future performance and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, but are not limited to, risks and uncertainties related to: macroeconomic conditions and the lingering effects of the COVID-19 pandemic; geopolitical instability; Lyell’s ability to submit planned INDs or initiate and execute clinical trials on the anticipated timelines, if at all; Lyell’s limited experience as a company in enrolling and conducting clinical trials, and lack of experience in completing clinical trials; Lyell’s ability to manufacture and supply its product candidates for its clinical trials; the nonclinical profiles of Lyell’s product candidates not translating in clinical trials; the potential for results from clinical trials to differ from preclinical, early clinical, preliminary or expected results; significant adverse events, toxicities or other undesirable side effects associated with Lyell’s product candidates; the significant uncertainty associated with Lyell’s product candidates ever receiving any regulatory approvals; Lyell’s ability to obtain, maintain or protect intellectual property rights related to its product candidates; the sufficiency of Lyell’s capital resources and need for additional capital to achieve its goals; and other risks, including those described under the heading “Risk Factors” in Lyell’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission (SEC) on February 28, 2023, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, filed with the SEC on August 8, 2023. Forward-looking statements contained in this press release are made as of this date, and Lyell undertakes no duty to update such information except as required under applicable law.

Contact:

Ellen Rose
Senior Vice President, Communications and Investor Relations
[email protected]



Arrivia, the World’s Largest Stand-Alone Travel Loyalty Provider, Partners with LiveVox to Optimize Traveler Customer Experience

Arrivia, the World’s Largest Stand-Alone Travel Loyalty Provider, Partners with LiveVox to Optimize Traveler Customer Experience

LiveVox Selected to Transform Contact Center Operations and Improve Customer Retention and Loyalty

SAN FRANCISCO–(BUSINESS WIRE)–LiveVox (Nasdaq: LVOX), a proven cloud CCaaS platform built to transform contact center performance, today announced that it has been selected by arrivia, a travel loyalty and membership solutions provider, to optimize and automate their customer experience. For more than 25 years, arrivia has powered travel loyalty and rewards programs for some of the world’s most respected cruise, hotel, resort, and financial brands. Since implementation began in June 2021, the LiveVox contact center platform has been used across all subscription, travel, cruise, membership, and back-office functions to remove agent performance obstacles and automate time-consuming tasks to improve customer retention and loyalty for arrivia’s partner brands.

“LiveVox’s customer engagement and analytics capabilities have been a game changer for arrivia, and the technology has helped transform our contact center operations, including productivity improvements of up to 20% for our sales operations,” said Travis Markel, COO, arrivia. “Arrivia has fully immersed itself with LiveVox in nearly every way – the tech has key visibility in every board meeting, is featured in every partner review and carries its very own brand within our organization. We look forward to expanding our relationship in the near future.”

LiveVox’s simple-to-manage cloud contact center solutions provide arrivia agents with a single pane of glass view and automation capabilities to deliver seamless and informed omnichannel customer journeys. By utilizing LiveVox’s pre-integrated modules, arrivia is also able to provide channels of choice, unify data streams, and initiate focused, outbound campaigns. As a result of working with LiveVox, arrivia has realized substantial benefit across its membership and travel businesses.

“Our collaboration with arrivia is a perfect example of how LiveVox uniquely helps companies consolidate legacy solutions to improve productivity and eliminate costs,” said John DiLullo, CEO, LiveVox. “Supporting travel loyalty program contact center solutions is a mixture of both art and science. We’re extremely proud of arrivia’s confidence in our solution, and in our ability to improve their contact center operations while also providing to them a meaningful financial benefit.”

To learn more about LiveVox’s proven cloud contact center platform, visit https://livevox.com/.

About LiveVox

LiveVox (Nasdaq: LVOX) is a proven cloud CCaaS platform that helps business leaders redefine customer engagement and transform their contact center’s performance. Decision-makers use LiveVox to improve customer experience, boost agent productivity, empower their managers, and enhance their system orchestration capabilities. Everything needed to deliver game-changing results can be seamlessly integrated and configured to maximize your success: Omnichannel Communications, AI, a Contact Center CRM, and Workforce Engagement Management tools.

For more than 20 years, clients of all sizes and industries have trusted LiveVox’s scalable and reliable cloud platform to power billions of omnichannel interactions every year. LiveVox is headquartered in San Francisco, with international offices in Medellin, Colombia and Bangalore, India.

To stay up to date with everything LiveVox, follow us @LiveVox, visit www.livevox.com or call one of our specialists at (844) 207-6663.

About arrivia

For more than 25 years, arrivia has powered travel loyalty and rewards programs for some of the world’s most respected cruise, hotel, resort, and financial brands, including American Express®, USAA®, and Marriott Vacation Club® by offering their customers more value through exclusive pricing and personalized options that inspire travel and customer loyalty. Arrivia’s travel privileges technology platform provides travel loyalty, booking, and marketing solutions to deliver exceptional value to customers and drive growth through exciting travel rewards and member benefits. To learn more about how arrivia helps companies drive growth, incentivize sales, boost affinity, and reward high-value customers, visit www.arrivia.com.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including those containing the words “anticipate,” “expect,” “suggests,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast,” “opportunity” and other similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon management estimates and forecasts and reflect the views, assumptions, expectations, and opinions of the LiveVox as of the date of this press release, and may include, without limitation, changes in general economic conditions, including as a result of COVID-19, all of which are accordingly subject to change. Any such estimates, assumptions, expectations, forecasts, views or opinions set forth in this press release constitute LiveVox’s judgments and should be regarded as indicative, preliminary and for illustrative purposes only. The forward-looking statements contained in this press release are subject to a number of factors, risks and uncertainties, some of which are not currently known to LiveVox, which may cause the LiveVox’s actual results, performance or financial condition to be materially different from the expectations of future results, performance of financial condition. Important factors, among others, that may affect actual results are described in the Company’s filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K filed with the SEC on March 2, 2023. Although forward-looking statements have been made in good faith and are based on assumptions that LiveVox believes to be reasonable, there is no assurance that the expected results will be achieved. LiveVox’s actual results may differ materially from the results discussed in forward-looking statements. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. These forward-looking statements are made only as of the date hereof, and LiveVox does not undertake any obligations to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

PR Contact for LiveVox

Katie Creaser

[email protected]


IR Contact for LiveVox

Ryan Gardella

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Technology Other Travel Other Professional Services Travel Consumer Professional Services Artificial Intelligence Other Technology Vacation Software Other Consumer Electronic Design Automation Data Management VoIP

MEDIA:

MACOM to Demonstrate and Showcase Optical Solutions at the 2023 European Conference on Optical Communications

MACOM to Demonstrate and Showcase Optical Solutions at the 2023 European Conference on Optical Communications

LOWELL, Mass.–(BUSINESS WIRE)–
MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, will host live demonstrations of its optical capabilities and showcase new products at the European Conference on Optical Communications (ECOC) in Glasgow, Scotland, October 2 – 4, 2023, Booth #704.

MACOM’s product management team will provide in-depth explanations of its new products and benefits of its solutions. Attendees will also have the opportunity to query and interact with the product line staff at the show floor during our live demonstration of 200Gbps/lane optical links and 200G/lane copper cables enabled by MACOM’s new chipsets.

200Gbps/lane Live Demonstrations:

  • 226Gbps Laser Driver and TIA for 1.6T Optical Modules

  • 226Gbps per lane Active Copper Cable Equalizers Extending DAC Reach for 800G/1.6T Applications

  • 800G Multimode Fiber QSFP-DD (with DSP Partner) based on 112 Gbps per lane VCSEL Drivers and TIAs

  • MACOM PURE DRIVE™ 800G Linear Pluggable Module Solutions

Showcase of New Products and Capabilities:

  • High-Performance PIN Photodetector for 212 G per lane Applications

  • 8-Channel SiPh Drivers for 800 G and 1.6 T Single-mode PAM4 Applications

  • 226 Gbps EML and SiPh drivers for 1.6 T Optical Modules

  • 130 Gbaud Drivers and TIAs for Coherent Applications

MACOM invites attendees to Booth #704 to meet with MACOM’s engineers to learn more about its newest products and MACOM’s broad portfolio.

Show Information:

Scottish Event Campus

Monday, October 2: 9:30 a.m. – 5:00 p.m.

Tuesday, October 3: 9:30 a.m. – 5:00 p.m.

Wednesday, October 4: 9:30 a.m. – 4:00 p.m.

For more information about ECOC, visit https://www.ecocexhibition.com/

About MACOM

MACOM designs and manufactures high-performance semiconductor products for the Telecommunications, Industrial and Defense, and Data Center industries. MACOM services over 6,000 customers annually with a broad product portfolio that incorporates RF, Microwave, Analog and Mixed Signal and Optical semiconductor technologies. MACOM has achieved certification to the IATF16949 automotive standard, the AS9100D aerospace standard, the ISO9001 international quality standard and the ISO14001 environmental management standard. MACOM operates facilities across the United States, Europe, Asia and is headquartered in Lowell, Massachusetts. To learn more, visit www.macom.com.

Company Contact:

MACOM Technology Solutions Holdings, Inc.

Stephen Ferranti

Vice President, Strategic Initiatives and Investor Relations

P: 978-656-2977

E: [email protected]

KEYWORDS: Massachusetts Europe United States United Kingdom North America

INDUSTRY KEYWORDS: Data Management Semiconductor Consumer Electronics Technology Other Technology Telecommunications Hardware

MEDIA:

Masco Corporation Announces Date for Earnings Release and Conference Call for 2023 Third Quarter

Masco Corporation Announces Date for Earnings Release and Conference Call for 2023 Third Quarter

LIVONIA, Mich.–(BUSINESS WIRE)–
Masco Corporation (NYSE: MAS) announced today that it will hold a conference call regarding 2023 third quarter results on Thursday, October 26, 2023 at 8:00 a.m. ET. The conference call will be hosted by Masco President and Chief Executive Officer Keith Allman. Participants in the call are asked to register five to ten minutes prior to the scheduled start time by dialing 888-259-6580 and from outside the U.S. at 416-764-8624. Please use the conference identification number 40185476.

The 2023 third quarter results and supplemental material will be distributed at 7:00 a.m. ET on October 26, 2023 and will be available on the Company’s website at www.masco.com.

The conference call will be webcast simultaneously and in its entirety through the Masco Corporation website. Shareholders, media representatives and others interested in Masco may participate in the webcast by registering through the Investor Relations section on the Company’s website.

A replay of the call will be available on Masco’s website or by phone by dialing 877-674-7070 and from outside the U.S. at 416-764-8692. Please use the playback passcode 185476#. The telephone replay will be available approximately two hours after the end of the call and continue through November 26, 2023.

Headquartered in Livonia, Michigan, Masco Corporation is a global leader in the design, manufacture and distribution of branded home improvement and building products. Our portfolio of industry-leading brands includes Behr® paint; Delta® and hansgrohe® faucets, bath and shower fixtures; Kichler® decorative and outdoor lighting; and HotSpring® spas. We leverage our powerful brands across product categories, sales channels and geographies to create value for our customers and shareholders. For more information about Masco Corporation, visit www.masco.com.

Investor Contact

David Chaika

Interim Chief Financial Officer

313.792.5500

[email protected]

 

KEYWORDS: Michigan United States North America

INDUSTRY KEYWORDS: Home Goods Other Natural Resources Forest Products Other Retail Other Construction & Property Residential Building & Real Estate Natural Resources Commercial Building & Real Estate Other Manufacturing Construction & Property Textiles Steel Specialty Engineering Manufacturing Building Systems Retail

MEDIA:

Logo
Logo

Wrangler® and Barbie® Launch Collection of Coordinating Denim, Jackets, Tops, Tees, and Dresses for Women and Girls

Wrangler® and Barbie® Launch Collection of Coordinating Denim, Jackets, Tops, Tees, and Dresses for Women and Girls

Wrangler x Barbie brings archival, western-inspired styles and plenty of pink

GREENSBORO, N.C.–(BUSINESS WIRE)–
Global denim brand and the leading authority in western fashion, Wrangler® today announced its collaboration with Mattel, Inc.’s Barbie, the #1 fashion doll brand inspiring a cultural phenomenon. The Wrangler x Barbie collection celebrates two brands with similar heritage, united in the desire to encourage women and girls to be strong, confident, free and fearlessly chase their dreams.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230927392948/en/

For many generations, Wrangler has represented and supported the hard-earned pursuits and dreams of the American West while the Barbie brand has empowered fans of all ages to believe that they can be anything. (Photo: Business Wire)

For many generations, Wrangler has represented and supported the hard-earned pursuits and dreams of the American West while the Barbie brand has empowered fans of all ages to believe that they can be anything. (Photo: Business Wire)

Capturing the imaginative, playful style of Barbie and featuring iconic silhouettes and quintessential western design elements from Wrangler – including a pink rendition of the iconic and unmistakable Wrangler back-pocket leather patch – Wrangler x Barbie features an assortment of mix-and-match pieces for women and girls. The collection contains the denim brand’s perfected bootcut jean and first Wrancher® Dress Jean for women in a vibrant Barbie pink. Bridging Wrangler’s roots and the Barbie brand’s signature California vibes, the collection also includes an assortment of casual and statement pieces across shirts, dresses, tees and jackets incorporating fierce colors, lively prints and a touch of western flair.

For many generations, Wrangler has represented and supported the hard-earned pursuits and dreams of the American West while the Barbie brand has empowered fans of all ages to believe that they can be anything. Barbie herself has been depicted as a farmer and an equestrian, so the Wrangler x Barbie collection fittingly incorporates western-inspired Barbie illustrations, patterns, textures and aesthetics for those who have always dared to dream.

“Particularly through the remarkable expansion of its female product categories over the years, Wrangler has earned a unique position in women’s fashion, offering western style that transcends lifestyles, occupations, economic backgrounds, genres, geographies and generations,” says Jenni Broyles, senior vice president, Wrangler. “Barbie has become a permanent and cultural symbol of empowerment, and with this collection we aim to encourage individuals from all walks of life to embrace their unique identities and make a statement that echoes across time.”

The collaboration is backed by iconic brand histories full of rich, symbolic and classic fashions and cultural moments, and inspired by two brands that have been making products long-cherished as collectible items passed down through generations. Wrangler x Barbie reimagines brand archives and pays homage to the Barbie brand’s history of experimenting with western-inspired fashion and her authentic western lifestyle, including her experience as a horse owner beginning in the 1970s.

Wrangler x Barbie is available on Wrangler.com and at key retailers, including Dillard’s, Buckle, Boot Barn and Cavender’s. To learn more about the collection, upcoming collaborations between Mattel and Wrangler, and the groundbreaking brands leading women to pursue their passions, follow @wrangler, @barbie and @barbiestyle.

About Wrangler®

Wrangler®, of Kontoor Brands (NYSE: KTB), has been an icon in authentic American style for 75 years. With a rich legacy rooted in the Western lifestyle, Wrangler is committed to offering superior quality and timeless design. Its collections for men, women, and children look and feel great, inspiring all those who wear them to be strong and ready for everyday life. Wrangler is available in retail stores worldwide, including flagship stores in Fort Worth and Greensboro, department stores, mass-market retailers, specialty shops, top western outfitters, and online. For more information, visit Wrangler.com.

About Mattel

Mattel is a leading global toy company and owner of one of the strongest catalogs of children’s and family entertainment franchises in the world. We create innovative products and experiences that inspire, entertain, and develop children through play. We engage consumers through our portfolio of iconic brands, including Barbie®, Hot Wheels®, Fisher-Price®, American Girl®, Thomas & Friends®, UNO®, Masters of the Universe®, Monster High® and MEGA®, as well as other popular intellectual properties that we own or license in partnership with global entertainment companies. Our offerings include film and television content, gaming and digital experiences, music, and live events. We operate in thirty-five locations and our products are available in more than 150 countries in collaboration with the world’s leading retail and ecommerce companies. Since its founding in 1945, Mattel is proud to be a trusted partner in empowering children to explore the wonder of childhood and reach their full potential. Visit us online at mattel.com.

Kaitlyn DeSimone [email protected]

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Children Online Retail Manufacturing Licensing (Entertainment) Women Entertainment Fashion Retail Toys Textiles Consumer

MEDIA:

Photo
Photo
Wrangler x Barbie features an assortment of mix-and-match pieces for women and girls. (Photo: Business Wire)
Photo
Photo
The Wrangler x Barbie collection fittingly incorporates western-inspired Barbie illustrations, patterns, textures and aesthetics for those who have always dared to dream. (Photo: Business Wire)
Photo
Photo
The collaboration is backed by iconic brand histories full of rich, symbolic and classic fashions and cultural moments, and inspired by two brands that have been making products long-cherished as collectible items passed down through generations (Photo: Business Wire)
Photo
Photo
For many generations, Wrangler has represented and supported the hard-earned pursuits and dreams of the American West while the Barbie brand has empowered fans of all ages to believe that they can be anything. (Photo: Business Wire)
Photo
Photo
Bridging Wrangler’s roots and the Barbie brand’s signature California vibes, the collection includes an assortment of casual and statement pieces across shirts, dresses, tees and jackets incorporating fierce colors, lively prints and a touch of western flair. (Photo: Business Wire)
Photo
Photo
Wrangler x Barbie reimagines brand archives and pays homage to the Barbie brand’s history of experimenting with western-inspired fashion and her authentic western lifestyle, including her experience as a horse owner beginning in the 1970s. (Photo: Business Wire)

Virpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation Studies

Virpax Pharmaceuticals Announces Results of Probudur Dose Escalation Studies

BERWYN, Pa.–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today announced results for two pre-clinical Probudur™ dose escalation studies.

The first study compared Probudur to Exparel® utilizing a planar incision model. Two doses of Probudur, at 3 mg and 6 mg, were administered to rats. The results demonstrated three times longer efficacy for Probudur than Exparel.

In the second study, two different formulations at the same dose of Probudur were compared to Exparel in rat incision models. In this study, Probudur demonstrated a four to five times longer effect than the comparable product.

“These IND enabling studies confirmed our results from earlier studies,” commented Anthony P. Mack, Chairman and CEO of Virpax Pharmaceuticals. “We only have a few additional studies to be performed and are on track to begin first-in-human trials of Probudur in 2024.”

Additional confirmational studies for efficacy, toxicity, and pharmacokinetics are ongoing with others planned in order for the Company to file an Investigational New Drug (IND) Application.

About Virpax Pharmaceuticals

Virpax is developing branded, non-addictive pain management products candidates using its proprietary technologies to optimize and target drug delivery. Virpax is initially seeking FDA approval for two prescription drug candidates that employ two different patented drug delivery platforms. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain and Envelta™ is an intranasal molecular envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. Virpax is also using its intranasal Molecular Envelope Technology (MET) to develop two other product candidates. PES200 is a product candidate being developed to manage post-traumatic stress disorder (PTSD) and NobrXiol™ is a product candidate being developed for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy. Virpax recently acquired global rights to NobrXiol. Virpax has competitive cooperative research and development agreements (CRADAs) for all three of its prescription drug candidates, two with the National Institutes of Health (NIH) and one with the Department of Defense (DOD). Virpax is also seeking approval of two nonprescription product candidates: AnQlar, which is being developed to inhibit viral replication caused by influenza or SARS-CoV-2, and Epoladerm™, which is a topical diclofenac spray film formulation being developed to manage pain associated with osteoarthritis. For more information, please visit virpaxpharma.com and follow us on Twitter, LinkedIn and YouTube.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and Private Securities Litigation Reform Act, as amended, including those described below. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions.

These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential,” “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms and include statements regarding the Company’s anticipated studies for efficacy, toxicity and pharmacokinetics, the Company’s filing of an IND Application, and the Company’s anticipated first-in-human trials of Probudur in 2024. These statements relate to future events and involve known and unknown risks, uncertainties, and other factors, including the Company’s ability to successfully complete research and further development and commercialization of Company drug candidates in current or future indications; the uncertainties inherent in clinical testing; the Company’s ability to manage and successfully complete clinical trials and the research and development efforts for multiple product candidates at varying stages of development; the timing, cost and uncertainty of obtaining regulatory approvals for the Company’s product candidates; the Company’s ability to protect its intellectual property; the loss of any executive officers or key personnel or consultants; competition; changes in the regulatory landscape or the imposition of regulations that affect the Company’s product candidates; the Company’s ability to continue to obtain capital to meet its long-term liquidity needs on acceptable terms, or at all, including the additional capital which will be necessary to complete clinical trials that the Company plans to initiate; and other factors listed under “Risk Factors” in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that the Company has filed with the U.S. Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor Relations:

Betsy Brod

Affinity Growth Advisors

[email protected]

(917) 923-8541

Media:

Robert Cavosi

RooneyPartners

[email protected]

(646) 638-9891

KEYWORDS: Pennsylvania New York United States North America

INDUSTRY KEYWORDS: Other Health Finance Practice Management Pharmaceutical Surgery Professional Services Medical Devices Infectious Diseases Hospitals Clinical Trials Biotechnology Science Veterinary Other Science Research Health

MEDIA:

Logo
Logo

GAN Announces Leadership Transition

GAN Announces Leadership Transition

Board member and industry veteran, Seamus McGill, appointed Interim Chief Executive Officer

IRVINE, Calif.–(BUSINESS WIRE)–
GAN Limited (the “Company” or “GAN”) (NASDAQ: GAN), a leading North American B2B technology provider of real money internet gaming solutions and a leading International B2C operator of Internet sports betting, announced that its Board of Directors has accepted the resignation of Dermot Smurfit from his position as the Company’s Chief Executive Officer and as a director of the Company and its operating subsidiaries. The Company and Mr. Smurfit are evaluating a consulting arrangement for Mr. Smurfit, who remains a substantial stockholder in the Company.

The Company has appointed Seamus McGill, its current Chairman of the Board, to the position of Interim Chief Executive Officer effective as of September 26, 2023. Mr. McGill brings 25 years of experience in the gaming and technology industries and joined the Board of GAN in April 2014.

“On behalf of the entire Board and GAN team, I want to extend our appreciation to Dermot for his commitment to the Company since joining twenty years ago. Under Mr. Smurfit’s leadership, GAN experienced many great accomplishments and reached numerous milestones as a Company,” commented McGill. “Having served on the Board since 2014, I have a deep understanding of the Company, our talented teams, and our market position. I am honored to assume leadership of all of the Company’s executive functions and have been heavily involved in our ongoing strategic review process. We will continue to evaluate the indications of interest that we have received and will work to optimize the process and its outcome for shareholders in due course.”

Seamus McGill Background

Mr. McGill brings 25 years of direct industry experience and has been a member of the board of directors for over nine years. Previously, Mr. McGill was President of JOINGO, a mobile software company. Prior to JOINGO, Mr. McGill spent five years at Aristocrat Technologies Limited as Chief Operating Officer helping drive outsized growth in North America including changing the strategic focus to recurring revenue games. Prior to Aristocrat, Mr. McGill was President of Cyberview Technology, Inc. and orchestrated its sale to International Game Technology plc. Mr. McGill held senior positions at WMS Gaming Inc. and as managing director of international operations helped spearhead the company’s growth into several new markets across the globe. He started his career in gaming with Mikohn Gaming Corporation. Prior to moving to the U.S., Mr. McGill worked for 7 years in Japan and 3 years in Singapore.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding future business opportunities as well as statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “anticipate” and similar statements of a future or forward-looking nature. These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Please refer to the Company’s annual, quarterly and current reports filed on Forms 10-K, 10-Q and 8-K from time to time with the Securities and Exchange Commission for a further discussion of the factors and risks associated with the business. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. The Company undertakes no obligation to update or revise any forward-looking statements for any reason except as required by law.

Investors:

GAN

Robert Shore

Vice President, IR and Capital Markets

(610) 812-3519

[email protected]

Alpha IR Group

Ryan Coleman or Davis Snyder

(312) 445-2870

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Software General Sports Sports Internet Online Technology Casino/Gaming Entertainment

MEDIA:

Heritage Insurance Company Deploys Guidewire Cloud to Enhance Claims Operations

Heritage Insurance Company Deploys Guidewire Cloud to Enhance Claims Operations

TAMPA, Fla. & SAN MATEO, Calif.–(BUSINESS WIRE)–Heritage Insurance Company (Heritage) and Guidewire (NYSE: GWRE) announced that Heritage successfully deployed Guidewire ClaimCenter on Guidewire Cloud to power claims operations, adapt to changing market demands, and deliver value to its agents and policyholders. The company implemented ClaimCenter on Guidewire Cloud simultaneously across all personal lines of business in the 16 states where it does business. Heritage also implemented the Guidewire VendorEngage digital application to offer digital capabilities to its vendors. Guidewire PartnerConnect Consulting Global Premier member PwC led the implementation project.

Heritage is currently implementing ClaimCenter to its commercial lines of business in its operating states. The implementations of Guidewire PolicyCenter and Guidewire BillingCenter will follow the completion of the ClaimCenter implementation, making the company a fully live Guidewire InsuranceSuite on Guidewire Cloud customer.

“Thanks to Guidewire’s configurability, as well as PwC’s project leadership, we were able to implement ClaimCenter on Guidewire Cloud on time and on budget. We were able to successfully convert nearly 240,000 claims onto ClaimCenter, which is a tremendous achievement,” said Heritage Chief Information Officer Sai Giridharan. “Leveraging ClaimCenter on Guidewire Cloud offers us scalability and stability, and we have received positive feedback about the system from our claims department.”

“With the implementation for Guidewire ClaimCenter and VendorEngage on Guidewire Cloud, it has improved our first-notice-of-loss (FNOL) intake process and provided greater end-to-end transparency to our claims examiners,” said Heritage Chief Claims Officer Joe Powers. “We now have the systems foundation to focus more on our people to help them better serve our policyholders.”

“Businesses of all sizes are seeing the value in embracing cloud transformation as a necessary step in their growth and Guidewire Cloud continues to be a leading tool in this journey,” said PwC Partner Imran Ilyas. “We are pleased that Heritage entrusted us with implementing ClaimCenter and VendorEngage on Guidewire Cloud and look forward to continuing their cloud transformation journey with the next Guidewire implementation projects.”

Guidewire Chief Customer Officer Christina Colby said, “Heritage is a premier provider of P&C insurance along the U.S. Gulf Coast, and we celebrate the company’s mission to deliver insurance products and services that offer the greatest value in the most challenging markets. We’re excited that Heritage is already benefiting from our partnership as they leverage ClaimCenter on Guidewire Cloud to ensure they meet their commitment to provide homeowners with the highest quality property insurance and some of the most competitive rates in the region. We look forward to continuing to strategically partner with them well into the future.”

Heritage also implemented SmartCOMM™ from Smart Communications for customer communications management. Guidewire is a reseller of Smart Communications, a Guidewire PartnerConnect Solution member.

About Heritage

Heritage Insurance Holdings, Inc. is a super-regional property and casualty insurance holding company. Through its insurance subsidiaries and a large network of experienced agents, the Company writes approximately $1.2 billion of gross personal and commercial residential and commercial general liability premiums across its multi-state footprint. For more information, please visit https://www.heritagepci.com/.

About Guidewire Software

Guidewire is the platform P&C insurers trust to engage, innovate, and grow efficiently. ​We combine digital, core, analytics, and machine learning to deliver our platform as a cloud service. More than 540 insurers in 40 countries, from new ventures to the largest and most complex in the world, run on Guidewire.

As a partner to our customers, we continually evolve to enable their success. We are proud of our unparalleled implementation track record, with more than 1,600 successful projects, supported by the largest R&D team and partner ecosystem in the industry. Our marketplace provides hundreds of applications that accelerate integration, localization, and innovation.

For more information, please visit http://www.guidewire.com/ and follow us on X (formerly known as Twitter) and LinkedIn.

NOTE: For information about Guidewire’s trademarks, visit https://www.guidewire.com/legal-notices.

Diana Stott

Director, Communications

Guidewire Software, Inc.

+1.650.781.9955

[email protected]

Renee Warden

Director of SEC Financial Reporting

Heritage Insurance Holdings, Inc

[email protected]

KEYWORDS: United States North America California Florida

INDUSTRY KEYWORDS: Professional Services Data Management Technology Software Finance Networks Internet

MEDIA:

Logo
Logo

Pinstripes Expands Senior Leadership Team, Hires Chief Financial Officer and Chief Marketing Officer in Advance of Public Listing

Pinstripes Expands Senior Leadership Team, Hires Chief Financial Officer and Chief Marketing Officer in Advance of Public Listing

Appoints Tony Querciagrossa as Chief Financial Officer and Shannon Keller as Chief Marketing Officer

Publishes Updated Investor Presentation and FilesRegistration Statement on Form S-4 in Connection With Its Proposed Business Combination With Banyan Acquisition Corp.

NORTHBROOK, Ill.–(BUSINESS WIRE)–
Pinstripes, Inc. (“Pinstripes,” or “the Company”), a best-in-class experiential dining and entertainment brand combining bistro, bowling, bocce and private event space, today announced additions to its leadership team, including the appointments of Tony Querciagrossa as Chief Financial Officer (CFO) and Shannon Keller as Chief Marketing Officer (CMO), both reporting directly to the Company’s Founder and CEO, Dale Schwartz.

“We’re very excited to welcome both Tony and Shannon to the Pinstripes team at this exciting time in our history,” said Schwartz. “Experiential dining and entertainment is in the midst of robust expansion and we are uniquely positioned to capitalize on the significant whitespace opportunities. These two strategic C-Suite positions will play an integral role in delivering on our growth strategy of scaling our winning combination of delicious food and timeless entertainment.”

“As we continue to move through the deSPAC process and Pinstripes prepares to become a publicly traded company, we could not be more pleased to welcome these two leaders to the executive team,” said Jerry Hyman, Chairman of Banyan Acquisition Corp. “We are confident that they will compliment the current management team and make an immediate, positive impact and soon help Pinstripes navigate the public markets.”

Tony Querciagrossa – Chief Financial Officer

Querciagrossa is a seasoned executive with more than 15 years of both public and private equity general management and CFO experience building and leading highly effective global teams across businesses with varying levels of scale and complexity. Most recently, Tony was President of Columbus Industries, Inc., a leading manufacturer of residential filtration and an operating company of Filtration Group Corporation. Prior to Columbus Industries, he was President of Purafil Inc. and before that Group CFO of Filtration Group’s Indoor Air Quality businesses. Previously, he served as VP Finance at Medline Industries, Inc, a large manufacturer and distributor of medical supplies with $20 billion in revenues. Querciagrossa began his career in finance with General Electric and holds a degree in finance from Northern Illinois University.

“I am excited to join Pinstripes at such a pivotal time in the company’s journey,” said Querciagrossa. “Pinstripes is experiencing first-hand the promising growth opportunities in the sector, having clearly separated itself from its peers, and I look forward to helping Dale and the rest of the team continue to lead in this space as we move towards becoming a public company.”

Shannon Keller – Chief Marketing Officer

Keller brings more than two decades of experience spearheading strategic marketing initiatives for leading organizations across a variety of verticals. She offers a depth of knowledge across all areas of marketing including branding, communications, digital, advertising and public relations. From 2015-2022, Keller served as Chief Marketing Officer of True Food Kitchen, an award-winning restaurant brand renowned for pioneering full-service healthy dining. During her tenure, she helped grow the multi-unit restaurant brand from 10 to 40 locations nationwide. Prior to True Food Kitchen, she held senior leadership roles at global marketing firms Weber Shandwick Worldwide and PMK*BNC, where she drove the strategic and creative marketing plans for some of the nation’s top consumer lifestyle brands. Keller earned a degree in communications from Loyola University of Maryland.

“I am delighted to become a part of the Pinstripes family and help amplify the important story that the brand has to share with the industry and consumers looking to connect with friends and family over made-from-scratch meals and exciting entertainment,” added Keller. “Pinstripes is in a category of its own, and I am eager to support the company’s growth strategy as we open additional locations throughout the U.S. and overseas.”

Updated Investor Deck

In connection with the proposed business combination transaction, Pinstripes recently released an updated version of its investor deck. The updated investor deck was filed with the SEC on September 27, 2023, and can be found at https://www.banyanacquisition.com/.

Filing of Registration Statement on Form S-4

Pinstripes also announced that it has recently filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 (the “Registration Statement”) in connection with the previously announced business combination between Pinstripes and Banyan Acquisition Corporation. (NYSE: BYN) (“Banyan”), a publicly traded special purpose acquisition company.

The Registration Statement, which can be found at link, contains a preliminary proxy statement and prospectus of Banyan and preliminary consent solicitation statement of Pinstripes in connection with the proposed business combination transaction. Although the Registration Statement has not yet become effective and the information contained therein is preliminary and subject to change, it provides important information about Pinstripes, Banyan and the proposed business combination transaction.

The Business Combination

The business combination transaction, currently targeted to close in the fourth quarter of 2023, is subject to the Registration Statement being declared effective by the SEC, approval of the transaction by the stockholders of Banyan and Pinstripes, and other customary closing conditions. Banyan’s shares of Class A common stock and warrants to purchase shares of Class A common stock are currently traded on the New York Stock Exchange under the ticker symbols “BYN” and “BYN.WS”, respectively. Upon completion of the transaction, the combined company will be named Pinstripes Holdings, Inc. and its shares of common stock and warrants to purchase shares of common stock are expected to be listed on the New York Stock Exchange under the ticker symbol “PNST” and “PNST WS”, respectively.

About Pinstripes, Inc.

Born in the Midwest, Pinstripes’ best-in-class venues offer a combination of made-from-scratch dining, bowling and bocce and flexible private event space. From its full-service Italian-American food and beverage menu to its gaming array of bowling and bocce, Pinstripes offers multi-generational activities seven days a week. Its elegant and spacious 25,000 – 38,000 square foot venues can accommodate groups of 20 to 1,500 people for private events, parties, and celebrations. For more information on Pinstripes, led by Founder and CEO Dale Schwartz, please visit www.pinstripes.com.

About Banyan Acquisition Corporation

Banyan Acquisition Corporation (NYSE: BYN) is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company is led by Chairman Jerry Hyman and Chief Executive Officer Keith Jaffee. For more information on Banyan Acquisition Corporation, please visit https://www.banyanacquisition.com/.

Additional Information and Where to Find It

On September 11, 2023, Banyan filed with the preliminary Registration Statement with the SEC, which included a preliminary proxy statement and prospectus of Banyan and preliminary consent solicitation statement of Pinstripes in connection with the proposed business combination transaction and related matters as described in the Registration Statement. After the Registration Statement is declared effective, Banyan will mail a definitive joint proxy statement/consent solicitation statement/prospectus and other relevant documents to its stockholders. Banyan’s stockholders, Pinstripes’ stockholders and other interested persons are advised to read the preliminary joint proxy statement/consent solicitation statement/prospectus, any amendments thereto, and, when available, the definitive joint proxy statement/consent solicitation statement/prospectus in connection with Banyan’s solicitation of proxies for its stockholders’ meeting to be held to approve the business combination and related matters, and the solicitation of written consents of Pinstripes’ stockholders to approve the business combination, because the joint proxy statement/consent solicitation statement/prospectus will contain important information about Banyan and Pinstripes and the proposed business combination. This press release is not a substitute for the Registration Statement, the definitive joint proxy statement/consent solicitation statement/prospectus or any other document that Banyan or Pinstripes will send to their stockholders in connection with the business combination.

INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ THE REGISTRATION STATEMENT, ANY AMENDMENTS THERETO, AND, WHEN AVAILABLE, THE JOINT PROXY STATEMENT/CONSENT SOLICITATION STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION AND THE PARTIES TO THE BUSINESS COMBINATION.

The definitive joint proxy statement/consent solicitation statement/prospectus will be mailed to stockholders of Banyan as of a record date to be established for voting on the proposed business combination and related matters and will be sent to stockholders of Pinstripes. Stockholders may obtain copies of the joint proxy statement/consent solicitation statement/prospectus, when available, without charge, at the SEC’s website at www.sec.gov or by directing a request to: Banyan Acquisition Corporation, 400 Skokie Blvd., Suite 820, Northbrook, IL 60062.

INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE BUSINESS COMBINATION OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

Participants in Solicitation

This press release is not a solicitation of a proxy from any investor or security holder. However, Banyan and Pinstripes and their respective directors, officers and other members of their management and employees may be deemed to be participants in the solicitation of proxies from Banyan’s stockholders with respect to the proposed business combination and related matters. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of the directors and officers of Banyan and Pinstripes in the joint proxy statement/consent solicitation statement/prospectus relating to the proposed business combination. These documents may be obtained free of charge from the sources indicated above.

No Offer or Solicitation

This press release is for informational purposes only, and is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy or subscribe for any securities or a solicitation of any vote of approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

Forward-Looking Statements

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Such forward-looking statements are often identified by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “forecasted,” “projected,” “potential,” “seem,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or otherwise indicate statements that are not of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements and factors that may cause actual results to differ materially from current expectations include, but are not limited to: risks related to the uncertainty of the projected financial information with respect to Pinstripes, the risk related to Pinstripes’ current growth strategy, Pinstripes’ ability to successfully open and integrate new locations, the risks related to the capital intensive nature of Pinstripes’ business, the ability of Pinstripes’ to attract new customers and retain existing customers and the impact of the COVID-19 pandemic, including the resulting labor shortage and inflation, on Pinstripes. The forgoing list of factors is not exhaustive and additional factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any subsequent definitive agreements with respect to the business combination; (2) the outcome of any legal proceedings that may be instituted against Banyan, the combined company or others following the announcement of the business combination and any definitive agreements with respect thereto; (3) the inability to complete the business combination due to the failure to obtain approval of the stockholders of Banyan or to satisfy (or to be waived) other conditions to closing (including, without limitation, the minimum cash condition); (4) changes to the proposed structure of the business combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the business combination; (5) the ability to meet stock exchange listing standards following the consummation of the business combination; (6) the risk that the business combination disrupts current plans and operations of Pinstripes as a result of the announcement and consummation of the business combination; (7) the ability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (8) costs related to the business combination; (9) changes in applicable laws or regulations; (10) the possibility that Pinstripes or the combined company may be adversely affected by other economic, business, and/or competitive factors and (11) Pinstripes’ estimates of operating results. The foregoing list of factors is not exhaustive.

The reader should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the joint proxy statement/consent solicitation statement/prospectus relating to the proposed business combination, Banyan’s final prospectus dated January 19, 2022, related to its initial public offering, Banyan’s Annual Report on Form 10-K filed with the SEC on March 31, 2023 and other documents filed by Banyan from time to time with the SEC.

The reader is cautioned not to place undue reliance on these forward-looking statements, which only speak as of the date made, are not a guarantee of future performance and are subject to a number of uncertainties, risks, assumptions and other factors, many of which are outside the control of Banyan and Pinstripes. Banyan and Pinstripes expressly disclaim any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the expectations of Banyan or Pinstripes with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Media:

ICR for Pinstripes:

[email protected]

Investor Relations:

ICR for Pinstripes:

[email protected]

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Casino/Gaming Entertainment Wine & Spirits Specialty Events/Concerts Other Entertainment General Entertainment Restaurant/Bar Food/Beverage Retail

MEDIA:

Logo
Logo